Drug intelligence / Profile preview

SDM201

Development stage: Unknown
Modality: Drug Delivery Systems

Overview

SDM201 is a polyethylene glycol-stabilized, lipid-shelled neutral microbubble. It is designed to enhance ultrasound-mediated gene transfer by interacting with plasmid DNA and target cells, thereby facilitating the delivery of genetic material. While effective in both in vitro and in vivo settings, its ability to enhance gene transfer is noted to be less potent than cationic or biotinylated cationic microbubbles, particularly at low concentrations.

Other names: neutral microbubble

Beyond the preview

Go deeper on SDM201.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SDM201.

Explore the full profile